CDKL5 deficiency disorder (CDD) is a rare genetic condition that causes severe seizures beginning in infancy, along with significant delays in motor skills, cognition, vision, and communication. It results from mutations in the CDKL5 gene on the X chromosome, which provides instructions for a protein essential to normal brain development. Seizures typically start within the first three months of life and are often resistant to standard treatments.
What the CDKL5 Gene Does
The CDKL5 gene produces a protein that plays a critical role in how brain cells connect and communicate with each other during early development. When this gene is mutated, the protein is either absent or doesn’t function properly, disrupting the formation and maintenance of the connections between neurons. This disruption is what drives both the seizures and the broad developmental challenges seen in CDD.
Because the CDKL5 gene sits on the X chromosome, the disorder affects males and females somewhat differently. Females have two X chromosomes, so one working copy can partially compensate for the mutated one, though this compensation varies widely. Males, with only one X chromosome, generally have no backup copy, which can lead to more severe presentations.
How Seizures Present and Change Over Time
Seizures are usually the first sign that something is wrong. They begin within the first three months of life and can appear as early as the first week after birth. In about 25% of affected infants, the initial seizure type is epileptic spasms: brief, sudden muscle jerks that may be subtle enough to miss at first. Notably, half of those infants with spasms show a normal-looking background pattern on EEG, which can make early diagnosis tricky.
The types of seizures shift as a child grows, often in a somewhat predictable pattern. The most common types include generalized tonic-clonic seizures (involving loss of consciousness, muscle rigidity, and convulsions), tonic seizures (sustained abnormal muscle contractions), and epileptic spasms. Some children experience a mix that blends features of spasms, tonic episodes, and hypermotor movements. The epilepsy in CDD is classified as intractable, meaning it typically does not respond well to anti-seizure medications. Most individuals continue to have seizures throughout their lives, though the frequency and severity can fluctuate.
Developmental and Motor Challenges
CDD causes significant developmental delay from birth, affecting nearly every domain: motor skills, language, cognition, and social interaction. Many children with CDD do not develop spoken language and rely on nonverbal communication methods such as eye gaze or assistive devices. Sitting independently, walking, and fine motor tasks like grasping objects are major challenges, and many individuals require full-time physical support throughout their lives.
Global hypotonia, a generalized low muscle tone, is common in infancy and early childhood. Over time, muscle tone abnormalities can evolve, and some adults develop increased stiffness or other changes in tone. Movement disorders, including repetitive hand movements, are also frequently observed.
Vision, Sleep, and Gut Problems
Cortical visual impairment is a hallmark feature of CDD. The eyes themselves may be structurally normal, but the brain has difficulty processing what they see. This can look like inconsistent eye contact, difficulty tracking objects, or seeming to “look through” people. Vision challenges affect learning, communication, and daily interaction with the environment.
Beyond the neurological core of the disorder, over 80% of people with CDD experience both sleep disturbances and gastrointestinal problems. Sleep issues often include fragmented nighttime sleep, difficulty falling asleep, and excessive daytime drowsiness. GI symptoms range from chronic constipation and reflux to difficulty swallowing, which can complicate feeding and nutrition. Recent research has found that the gut microbiome in people with CDD differs from that of healthy individuals, showing a more pro-inflammatory profile, though the clinical significance of this is still being explored.
How CDD Is Diagnosed
CDD is confirmed through genetic testing that identifies a mutation in the CDKL5 gene. Before genetic testing was widely available, many children with CDD were misdiagnosed with other conditions, particularly atypical Rett syndrome or unspecified epileptic encephalopathy. Today, when an infant presents with early-onset seizures that don’t respond to treatment, genetic testing panels that screen for epilepsy-related genes can identify CDKL5 mutations relatively quickly.
EEG findings in CDD are not always distinctive, which is one reason diagnosis historically took so long. The lack of a classic EEG signature, especially in infants whose spasms occur without the typical chaotic brain wave pattern expected in infantile spasms, means genetic testing is essential rather than optional for a definitive diagnosis.
How CDD Differs From Rett Syndrome
CDD was once classified as a variant of Rett syndrome because the two conditions share some overlapping features, including repetitive hand movements, limited speech, and seizures. They are now recognized as distinct disorders with different genetic causes. Rett syndrome is caused by mutations in the MECP2 gene, while CDD involves the CDKL5 gene.
The clinical differences are meaningful. CDD causes severe developmental delay from birth and seizures before three months of age. Rett syndrome, by contrast, typically involves a period of apparently normal development followed by a regression phase, usually between 6 and 18 months. Seizures and sleep disturbances are more common and more severe in CDD, while regression and spinal curvature (scoliosis) are more characteristic of Rett syndrome. Recognizing CDD as its own condition has been important for guiding treatment decisions and connecting families with the right resources.
Living With CDD Into Adulthood
Most of what clinicians know about CDD has come from studying children, but data on adults is growing. A study of 67 adults with CDD (median age 24) found that all but one had epilepsy, with seizures typically beginning as spasms or tonic episodes before four months of age. Those who experienced seizures in the neonatal period tended to reach fewer developmental milestones overall and were more likely to have abnormal muscle tone and heart conduction abnormalities in adulthood.
CDD is a lifelong condition. Individuals require ongoing support for seizure management, mobility, communication, feeding, and daily living. The focus of care shifts over time, from intensive seizure management and early intervention therapies in childhood to maintaining quality of life, managing comorbidities, and supporting caregivers in adulthood. Physical therapy, occupational therapy, vision services, and augmentative communication tools all play roles throughout the lifespan.